This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Medication did not decrease cognitive loss in patients with Alzheimer's disease

January 9th, 2018

Bottom Line: The use of the drug idalopirdine for six months did not improve or reduce the loss of cognition for patients with mild to moderate Alzheimer disease.

Why The Research Is Interesting: Two phase 2 trials have suggested that a certain type of drug, a selective 5-hydroxytryptamine-6 receptor antagonist, such as idalopirdine, may improve cognition in Alzheimer disease when added with another type of drug, cholinesterase inhibitors.

Who: 2,525 patients ages 50 years or older with mild to moderate Alzheimer disease

When: October 2013 to January 2017

What (Study Measures): Changes in measures of cognition from study entry to 24 weeks.

How (Study Design): Three randomized clinical trials, in which patients were assigned to receive idalopirdine or placebo added to a cholinesterase inhibitor. Randomized clinical trials allow for the strongest inferences to be made about the true effect of an intervention such as a medication or a procedure.

Authors: Alireza Atri, M.D., Ph.D., of California Pacific Medical Center, San Francisco, and Brigham and Women's Hospital/Harvard Medical School, Boston, and coauthors

Results and Study Conclusions: Six months of idalopirdine treatment added to cholinesterase inhibitor therapy did not improve cognition or decrease cognitive loss in patients with mild to moderate Alzheimer disease. These findings do not support the use of idalopirdine for the treatment of Alzheimer disease.

Study Limitations: There was no requirement for evidence of Alzheimer disease biomarker positivity for inclusion in a trial, which may have allowed some patients to be included without having Alzheimer disease pathology.

More information:
jamanetwork.com/journals/jama/ … 1001/jama.2017.20373

Provided by JAMA

Citation: Medication did not decrease cognitive loss in patients with Alzheimer's disease (2018, January 9) retrieved 29 March 2024 from https://sciencex.com/wire-news/276967079/medication-did-not-decrease-cognitive-loss-in-patients-with-alzh.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.